Evidence map›Paper›PMID 38916545›Full record

ReviewEmerging infectious diseases2024

Strategies to Enhance COVID-19 Vaccine Uptake among Prioritized Groups, Uganda-Lessons Learned and Recommendations for Future Pandemics.

Daniel Kiiza, Judith Nanyondo Semanda, Boneventure Brian Kawere, Claire Ajore, Christopher Kaliisa Wasswa, Andrew Kwiringira, Emmanuel Tumukugize, Joel Sserubidde, Nashiba Namyalo, Ronald Baker Wadria and 13 more

Abstract readReview
In one paragraph

Review in Emerging infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Daniel Kiiza
Judith Nanyondo Semanda
Boneventure Brian Kawere
Claire Ajore
Christopher Kaliisa Wasswa
Andrew Kwiringira
Emmanuel Tumukugize
Joel Sserubidde
Nashiba Namyalo
Ronald Baker Wadria
Peter Mukiibi
Julie Kasule
Ivan Chemos
Acham Winfred Ruth
Ritah Atugonza
Flora Banage
Yvette Wibabara
Immaculate Ampaire
Alfred Driwale
Waverly Vosburgh
Lisa Nelson
Mohammed Lamorde
Amy Boore

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 vaccination was launched in March 2021 in Uganda and initially prioritized persons >50 years of age, persons with underlying conditions, healthcare workers, teachers, and security forces. However, uptake remained low 5 months after the program launch. Makerere University's Infectious Diseases Institute supported Uganda's Ministry of Health in optimizing COVID-19 vaccination uptake models by using point-of-care, place of worship, and place of work engagement and the Social Assistance Grant for Empowerment model in 47 of 135 districts in Uganda, where we trained influencers to support mobilization for vaccination outreach under each model. During July-December, vaccination rates increased significantly in targeted regions, from 92% to 130% for healthcare workers, 40% to 90% for teachers, 25% to 33% for security personnel, 6% to 15% for persons >50 years of age, and 6% to 11% for persons with underlying conditions. Our approach could be adopted in other targeted vaccination campaigns for future pandemics.

Indexed as

COVID-19COVID-19 VaccinesSARS-CoV-2AdultFemaleHealth PersonnelHumansImmunization ProgramsMaleMiddle AgedPandemicsUgandaVaccinationCOVID-19 VaccinesCOVID-19high-priority populationsrespiratory infectionsSARS-CoV-2Ugandavaccine-preventable diseasesvaccinesviruseszoonoses

Identifiers

PMID38916545
PMCPMC11210662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.